2017
DOI: 10.1038/s41929-017-0003-3
|View full text |Cite
|
Sign up to set email alerts
|

Magnetic field remotely controlled selective biocatalysis

Abstract: M aterials that efficiently release biological molecules or therapeutic chemicals on demand using exposure to remotely controlled and safe external sources of energy, such as magnetic fields, could find applications for drug delivery 1 , biotechnology 2,3 and biosensors 4 . Because live tissue and synthetic polymers are not responsive to weak magnetic fields, the development of magnetic-field-responsive soft materials has been reported by combining magnetic nanoparticles and stimuli-responsive soft materials 5… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
75
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 89 publications
(75 citation statements)
references
References 41 publications
0
75
0
Order By: Relevance
“…The drawbacks are the complexity of use, the cost and the specific implementation for a surgeon. The typical ranges of use in frequency of the magnetic field goes from 100 < f < 437 kHz; 30 < time < 60 min; B < 100 mT . Current issues with the use of magnetic nanomaterials as stimuli‐responsive systems is that they should be as least cytotoxic as possible.…”
Section: Criteria and Key Issues To Design Smart Stimuli Responsive Smentioning
confidence: 99%
See 1 more Smart Citation
“…The drawbacks are the complexity of use, the cost and the specific implementation for a surgeon. The typical ranges of use in frequency of the magnetic field goes from 100 < f < 437 kHz; 30 < time < 60 min; B < 100 mT . Current issues with the use of magnetic nanomaterials as stimuli‐responsive systems is that they should be as least cytotoxic as possible.…”
Section: Criteria and Key Issues To Design Smart Stimuli Responsive Smentioning
confidence: 99%
“…The typical ranges of use in frequency of the magnetic field goes from 100 < f < 437 kHz; 30 < time < 60 min; B < 100 mT. [42,43] Current issues with the use of magnetic nanomaterials as stimuli-responsive systems is that they should be as least cytotoxic as possible. Even if metallic NPs or cobalt or zinc-doped ferrites would be highly preferred for their high saturation magnetization, they would induce important toxicity because of the release of heavy metals.…”
Section: Biomedical Implementation Of the Remotely Responsive Scaffoldmentioning
confidence: 99%
“…Zakharchenko et al. investigated the magnetic field–responsive compartmentalization of biocatalytic reactions for the remotely controlled release of drugs or (bio)chemicals . The concept is implemented by fabricating two distinctive magnetic core–shell nanoparticles, E and S, where E‐particles are grafted with PAA‐b‐PPEGMA and conjugated with the enzyme, and S‐particles are similarly decorated with PAA‐b‐PPEGMA and then loaded with the substrate.…”
Section: Stimuli‐responsive Mnp‐based Drug Delivery Systems For Biomementioning
confidence: 99%
“…In particular, the presence of oriented factors in environment lead to occurrence of directed movement patterns, different from pure diffusion (Armsworth and Bode 1999, Belgacem and Cosner 1995, Cantrell et al 2006. In this concern, it is worthwhile to mention also the modern technologies of controlled drug delivery, using an external oriented magnetic field (Zakharchenko et al 2018), and the implants based on arrays of oriented TiO 2 nanotubes, which control the directed release of drugs (Losic et al 2015, Wang et al 2017.…”
mentioning
confidence: 99%